These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2894520)

  • 21. An update on the status of the treatment of rheumatoid arthritis by lymphapheresis.
    Karsh J
    Int J Artif Organs; 1985 Jul; 8 Suppl 2():35-8. PubMed ID: 3876998
    [No Abstract]   [Full Text] [Related]  

  • 22. Nondepleting humanized anti-CD4 monoclonal antibody in patients with refractory rheumatoid arthritis.
    Moreland LW; Haverty TP; Wacholtz MC; Knowles RW; Bucy RP; Heck LW; Koopman WJ
    J Rheumatol; 1998 Feb; 25(2):221-8. PubMed ID: 9489810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The humoral response in rheumatoid arthritis and the effect of B-cell depleting therapy].
    Thurlings RM; Vos K; Gerlag DM; Tak PP
    Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1657-61. PubMed ID: 16922350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis.
    Wendling D; Wijdenes J; Racadot E; Morel-Fourrier B
    J Rheumatol; 1991 Mar; 18(3):325-7. PubMed ID: 1713269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Towards a selective immunotherapy of rheumatoid polyarthritis].
    Sany J
    Presse Med; 1993 Apr; 22(14):659-61. PubMed ID: 8511111
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-CD4 monoclonal antibodies in rheumatoid arthritis.
    Choy EH; Kingsley GH; Panayi GS
    Springer Semin Immunopathol; 1998; 20(1-2):261-73. PubMed ID: 9836381
    [No Abstract]   [Full Text] [Related]  

  • 27. Biologic interventions in rheumatoid arthritis.
    Cush JJ; Kavanaugh AF
    Rheum Dis Clin North Am; 1995 Aug; 21(3):797-816. PubMed ID: 8619100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-CD4 therapy in rheumatoid arthritis.
    Choy EH; Kingsley GH
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S147-9. PubMed ID: 8100751
    [No Abstract]   [Full Text] [Related]  

  • 29. [Monoclonal antibodies and rheumatoid polyarthritis].
    Wendling D
    Rev Med Interne; 1993; 14(7):705-14. PubMed ID: 8191073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6 antibodies in rheumatoid arthritis.
    Wijdenes J; Racadot E; Wendling D
    J Interferon Res; 1994 Oct; 14(5):297-8. PubMed ID: 7861036
    [No Abstract]   [Full Text] [Related]  

  • 31. [Monoclonal antibody assessment of lymphocyte subpopulations in rheumatoid arthritis in adult patients in relation to stage and treatment].
    Pappalardo A; Musso M; Sallì L; Di Prima P; Accurso V; Caradonna E
    Minerva Med; 1988 Mar; 79(3):187-92. PubMed ID: 3258972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Demonstration of a subpopulation of T-lymphocytes by a monoclonal lymphocytotoxic antibody produced by cellular hybridization in slightly developed rheumatoid arthritis].
    Mercier P; Dallest R; Garborit P; Blachère C; Roux H
    Rev Rhum Mal Osteoartic; 1981 Oct; 48(10):621-5. PubMed ID: 6975497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted antibody therapy and relevant novel biomarkers for precision medicine for rheumatoid arthritis.
    Kaneko Y; Takeuchi T
    Int Immunol; 2017 Dec; 29(11):511-517. PubMed ID: 29069431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-CD4 treatment of patients with rheumatoid arthritis. Is there still a place for this treatment principle in RA?
    Kalden JR
    Clin Exp Rheumatol; 1994; 12 Suppl 11():S67-9. PubMed ID: 7768057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New therapeutic approaches in rheumatoid arthritis.
    Herzog C; Walker C; Pichler WJ
    Concepts Immunopathol; 1989; 7():79-105. PubMed ID: 2571415
    [No Abstract]   [Full Text] [Related]  

  • 36. Gammaglobulins, autoantibodies, therapeutic antibodies and anti-drug antibodies in rheumatoid arthritis.
    Gottenberg JE
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):115-7. PubMed ID: 25546785
    [No Abstract]   [Full Text] [Related]  

  • 37. Biologic DMARD may be insufficient to inhibit CCL20 pathway in rheumatoid arthritis.
    Leng RX; Ye DQ
    J Rheumatol; 2010 Nov; 37(11):2430. PubMed ID: 21041265
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prospects of immunotherapy in rheumatoid arthritis].
    Lotz M
    Rev Rhum Ed Fr; 1993 Jan; 60(1):3-9. PubMed ID: 8242024
    [No Abstract]   [Full Text] [Related]  

  • 39. Humanised monoclonal antibody therapy for rheumatoid arthritis.
    Isaacs JD; Watts RA; Hazleman BL; Hale G; Keogan MT; Cobbold SP; Waldmann H
    Lancet; 1992 Sep; 340(8822):748-52. PubMed ID: 1356177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody.
    Mauri C; Chu CQ; Woodrow D; Mori L; Londei M
    J Immunol; 1997 Nov; 159(10):5032-41. PubMed ID: 9366431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.